Quick answers
- What is Paclitaxel protein-bound particles?
- Paclitaxel protein-bound particles is a brand name of Paclitaxel, a prescription medicine. The FDA NDC Directory lists 1 Paclitaxel protein-bound particles product in 1 strength and form.
- Who makes Paclitaxel protein-bound particles?
- Cipla holds the FDA application for Paclitaxel protein-bound particles (ANDA209657, approved April 10, 2025).
- Is there a generic or store brand of Paclitaxel protein-bound particles?
- Yes. The FDA NDC Directory lists 9 other products with the same active ingredients, strength and form as a Paclitaxel protein-bound particles product, 6 of them generic. Ask your pharmacist whether one is right for you.
- Has Paclitaxel protein-bound particles been recalled?
- No recall linked to Paclitaxel protein-bound particles products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Paclitaxel protein-bound particles is
Each Paclitaxel protein-bound particles product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Paclitaxel · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| paclitaxel 100 mg/20 mL injection, powder, lyophilized, for suspension (intravenous) | Paclitaxel protein-bound particles | 9 products, 9 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Paclitaxel →
FDA approval
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| ANDA209657 | Cipla | April 10, 2025 | 1 |
Companies that list Paclitaxel protein-bound particles
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Paclitaxel protein-bound particles products.
- Cipla USA Inc.1 product
Recalls
No recall linked to Paclitaxel protein-bound particles products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.